Euroespes (Spain) Today
| EEP Stock | EUR 0.34 0.20 37.04% |
Performance0 of 100
| Odds Of DistressOver 65
|
Euroespes is trading at 0.34 as of the 31st of January 2025, a 37.04% down since the beginning of the trading day. The stock's open price was 0.54. Euroespes has more than 65 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 31st of January 2025. Click here to learn more.
Euroespes, S.A., a medical center, provides medical services for the prevention, diagnosis, and treatment of central nervous system disorders and other diseases in Spain and internationally. Euroespes, S.A. was founded in 1991 and is based in A Corua, Spain. The company has 11.59 M outstanding shares. More on Euroespes SA
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Euroespes Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Euroespes' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Euroespes or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Diagnostics & Research, Healthcare (View all Sectors) |
Euroespes SA (EEP) is traded on Madrid Exchange in Spain and employs 40 people. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Euroespes's market, we take the total number of its shares issued and multiply it by Euroespes's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Euroespes SA operates under Healthcare sector and is part of Diagnostics & Research industry. The entity has 11.59 M outstanding shares.
Euroespes SA has accumulated about 3.45 M in cash with 16.6 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.33.
Check Euroespes Probability Of Bankruptcy
Ownership AllocationEuroespes SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.8 percent of Euroespes SA outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Euroespes Ownership Details
Euroespes Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Euroespes without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Other Information on Investing in Euroespes Stock
Euroespes financial ratios help investors to determine whether Euroespes Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Euroespes with respect to the benefits of owning Euroespes security.